Why the study?
Does elective stent-graft placement (TEVAR) improve 2-year survival and adverse event rates in survivors of uncomplicated type B aortic dissection?
Does elective stent-graft placement (TEVAR) improve 2-year survival and adverse event rates in survivors of uncomplicated type B aortic dissection?
In survivors of uncomplicated type B aortic dissection, elective TEVAR does not improve 2-year survival or adverse event rates despite inducing favorable aortic remodeling.
Elective TEVAR should not be routine for uncomplicated type B aortic dissection; challenges remodeling as a reliable surrogate for clinical benefit.
In the first randomized study on elective stent-graft placement in survivors of uncomplicated type B aortic dissection, TEVAR failed to improve 2-year survival and adverse event rates despite favorable aortic remodeling.
No takes yet. Share an insight, caveat, or question.
Nienaber et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: